Concise Review: Growth Differentiation Factor 15 in Pathology: A Clinical Role?

被引:170
作者
Corre, Jill [1 ,2 ]
Hebraud, Benjamin [3 ]
Bourin, Philippe [4 ]
机构
[1] Inst Natl Sante & Rech Med INSERM, U1037, Toulouse, France
[2] Univ Hosp Purpan, Hematol Lab, Toulouse, France
[3] Univ Hosp Purpan, Dept Hematol, Toulouse, France
[4] CSA21, F-31100 Toulouse, France
关键词
Cancer; Clinical translation; Drug target; Malignancy; MACROPHAGE INHIBITORY CYTOKINE-1; TGF-BETA SUPERFAMILY; ACTIVATED GENE NAG-1; MESENCHYMAL STEM-CELLS; PROSTATE-CANCER CELLS; MULTIPLE-MYELOMA; PANCREATIC ADENOCARCINOMA; RISK STRATIFICATION; HEART-FAILURE; HUMAN BREAST;
D O I
10.5966/sctm.2013-0055
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Growth differentiation factor 15 (GDF15) is a divergent member of the transforming growth factor 13 family discovered in a broad range of cells, as indicated by the diversity of its nomenclature. However, the only tissue that expresses a high amount of GDF15 in the physiologic state is placenta. GDF15 is easily detected in blood, and its concentration varies with age. In fact, increased blood concentration of GDF15 is associated with numerous pathological conditions. However, the biological significance underlying these observations is far from clear. GDF15 could have a positive or negative role depending on the state of cells or their environment. Furthermore, study of its biology is hampered by lack of knowledge of its receptor and thus the signaling pathways that drive its action. GDF15 seems to be an integrative signal in pathologic conditions, giving information on severity of disease. Its effectiveness in classifying patients to modulate treatment remains to be shown. Development of therapeutic interventions with GDF15 or anti-GDF15 agents remains difficult until we uncover the mechanism that drives its activity.
引用
收藏
页码:946 / 952
页数:7
相关论文
共 72 条
[31]   Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy:: Identification of a cytoprotective mechanism involving growth differentiation factor 15 [J].
Huang, Chung-Ying ;
Beer, Tomasz M. ;
Higano, Celestia S. ;
True, Lawrence D. ;
Vessella, Robert ;
Lange, Paulh. ;
Garzotto, Mark ;
Nelson, Peter S. .
CLINICAL CANCER RESEARCH, 2007, 13 (19) :5825-5833
[32]   Macrophage Inhibitory Cytokine-1 Regulates Melanoma Vascular Development [J].
Huh, Sung Jin ;
Chung, Chin-Ying ;
Sharma, Arati ;
Robertson, Gavin P. .
AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (06) :2948-2957
[33]   Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1 [J].
Johnen, Heiko ;
Lin, Shu ;
Kuffner, Tamara ;
Brown, David A. ;
Tsai, Vicky Wang-Wei ;
Bauskin, Asne R. ;
Wu, Liyun ;
Pankhurst, Greg ;
Jiang, Lele ;
Junankar, Simon ;
Hunter, Mark ;
Fairlie, W. Douglas ;
Lee, Nicola J. ;
Enriquez, Ronaldo F. ;
Baldock, Paul A. ;
Corey, Eva ;
Apple, Fred S. ;
Murakami, MaryAnn M. ;
Lin, En-Ju ;
Wang, Chuansong ;
During, Matthew J. ;
Sainsbury, Amanda ;
Herzog, Herbert ;
Breit, Samuel N. .
NATURE MEDICINE, 2007, 13 (11) :1333-1340
[34]   Increased expression of the TGF-b superfamily cytokine MIC-1/GDF15 protects ApoE-/- mice from the development of atherosclerosis [J].
Johnen, Heiko ;
Kuffner, Tamara ;
Brown, David A. ;
Wu, Ben J. ;
Stocker, Roland ;
Breit, Samuel N. .
CARDIOVASCULAR PATHOLOGY, 2012, 21 (06) :499-505
[35]   The transforming growth factor-β superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury [J].
Kempf, T ;
Eden, M ;
Strelau, J ;
Naguib, M ;
Willenbockel, C ;
Tongers, J ;
Heineke, J ;
Kotlarz, D ;
Xu, J ;
Molkentin, JD ;
Niessen, HW ;
Drexler, H ;
Wollert, KC .
CIRCULATION RESEARCH, 2006, 98 (03) :351-360
[36]   Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction [J].
Kempf, Tibor ;
Bjoerklund, Erik ;
Olofsson, Sylvia ;
Lindahl, Bertil ;
Allhoff, Tim ;
Peter, Timo ;
Tongers, Jorn ;
Wollert, Kai C. ;
Wallentin, Lars .
EUROPEAN HEART JOURNAL, 2007, 28 (23) :2858-2865
[37]   Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure [J].
Kempf, Tibor ;
von Haehling, Stephan ;
Peter, Timo ;
Allhoff, Tim ;
Cicoira, Mariantonietta ;
Doehner, Wolfram ;
Ponikowski, Piotr ;
Filippatos, Gerasimos S. ;
Rozentryt, Plotr ;
Drexler, Helmut ;
Anker, Stefan D. ;
Wollert, Kai C. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (11) :1054-1060
[38]   Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells [J].
Kim, Kwang-Kyu ;
Lee, Jung Joon ;
Yang, Young ;
You, Kwan-Hee ;
Lee, Jeong-Hyung .
CARCINOGENESIS, 2008, 29 (04) :704-712
[39]   Plasma Markers for Identifying Patients with Metastatic Melanoma [J].
Kluger, Harriet M. ;
Hoyt, Kathleen ;
Bacchiocchi, Antonella ;
Mayer, Tina ;
Kirsch, Jonathan ;
Kluger, Yuval ;
Sznol, Mario ;
Ariyan, Stephan ;
Molinaro, Annette ;
Halaban, Ruth .
CLINICAL CANCER RESEARCH, 2011, 17 (08) :2417-2425
[40]   Serum markers in patients with resectable pancreatic adenocarcinoma: Macrophage inhibitory cytokine 1 versus CA19-9 [J].
Koopmann, J ;
Rosenzweig, CNW ;
Zhang, Z ;
Canto, MI ;
Brown, DA ;
Hunter, M ;
Yeo, C ;
Chan, DW ;
Breit, SN ;
Goggins, M .
CLINICAL CANCER RESEARCH, 2006, 12 (02) :442-446